Evidence map›Paper›PMID 37823909›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

p53 stabilisation potentiates [

Hanna Berglund, Sara Lundsten Salomonsson, Tabassom Mohajershojai, Fernando Jose Ferrer Gago, David P Lane, Marika Nestor

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. [EJNMMI research · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Comparison ofHeliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Hanna Berglund *Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden.
Sara Lundsten Salomonsson *Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden.
Tabassom MohajershojaiDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden.
Fernando Jose Ferrer Gagop53Lab, Agency for Science Technology and Research (A*STAR), Singapore, 138648, Singapore.
David P LaneDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden.
Marika NestorDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden. marika.nestor@igp.uu.se.ORCID 0000-0003-4662-3142
Uppsala University · SEAgency for Science, Technology and Research · SG

Funding

Barncancerfonden PR2020-0023Cancerfonden CAN 20 0191Cancerfonden CAN 21 1534Vetenskapsrådet 2020-01377
6 · The paper itself

Abstract

purposeMolecular radiotherapy is a treatment modality that is highly suitable for targeting micrometastases and [

methodsThis study investigated the use of the p53 stabilising peptide VIP116 and [

resultsThe results demonstrated that monotherapy with either VIP116 or [

conclusionIn conclusion, the combination of VIP116 and [

Indexed as

NeuroblastomaNeuroendocrine TumorsOrganometallic CompoundsPositron-Emission TomographyRadionuclide ImagingAnimalsHeterograftsHumansMiceOctreotideTumor Suppressor Protein p53copper dotatate CU-64OctreotideOrganometallic CompoundsTumor Suppressor Protein p53[177Lu]Lu-DOTATATEMolecular radiotherapyNeuroblastomap53Radiosensitisation

Identifiers

PMID37823909
PMCPMC10796565
OpenAlexW4387563326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.